Reversal of multidrug resistance by magnetic chitosan-Fe3O4 nanoparticle-encapsulated MDR1 siRNA in glioblastoma cell line

Neurological Research

Volumn 35, Issue 8, 2013, Pages 821-828

  Zhao, Peng ^a   Wang, Hongyun ^b   Gao, Hua ^b   Li, Chuzhong ^b   Zhang, Yazhuo ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Gene therapy; Glioma; Nanoparticle; RNA interference

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHITOSAN; DOXORUBICIN; GREEN FLUORESCENT PROTEIN; IRON OXIDE; LUCIFERASE; MULTIDRUG RESISTANCE PROTEIN; NANOPARTICLE; SMALL INTERFERING RNA; VINCRISTINE;

AGAR GEL ELECTROPHORESIS; ARTICLE; CANCER GENE THERAPY; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FLOW CYTOMETRY; GENE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IC 50; IMMUNOCYTOCHEMISTRY; MDR1 GENE; MULTIDRUG RESISTANCE; NANOENCAPSULATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FERRIC COMPOUNDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; NANOPARTICLES; P-GLYCOPROTEIN; RNA, SMALL INTERFERING; TRANSFECTION; VINCRISTINE;

EID: 84884179298     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000218     Document Type: Article

References (28)

1. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21:2683-710.
2. Rosenfeld MR, Pruitt AA. Management of malignant gliomas and primary CNS lymphoma: standard of care and future directions. Continuum (Minneap Minn). 2012;18:406-15.
3. Tews D S, Nissen A, Kulgen C, Gaumann AK. Drug resistance-associated factors in primary and secondary glioblastomas and their pre-cursor tumors. J Neurooncol. 2000;50:227-37.
4. Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci. 2004;25:423-9.
5. Shirasaka Y, Onishi Y, Sakurai A, Nakagawa H, Ishikawa T, Yamashita S. Evaluation of human P-glycoprotein (MDR1/ ABCB1) ATPase activity assay method by comparing with in vitro transport measurements: Michaelis-Menten kinetic analysis to estimate the affinity of P-glycoprotein to drugs. Biol Pharm Bull. 2006;29:2465-71.
6. Zhao P, Zhang Y, Sun M, He Y. Reversion of multidrug resistance in human glioma by RNA interference. Neurol Res. 2008;30:562-6.
7. Dykxhoorn DM. RNA interference as an anticancer therapy: a patent perspective. Expert Opin Ther Pat. 2009;19:475-91.
8. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer. 2011;11:59-67.
9. Moore CB, Guthrie EH, Huang MT, Taxman DJ. Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown. Methods Mol Biol. 2010;629:141-58.
10. Hamasaki T, Suzuki H, Shirohzu H, Matsumoto T, D'Alessandro-Gabazza CN, Gil-Bernabe P, et al. Efficacy of a novel class of RNA interference therapeutic agents. PLoS One. 2012;7:e42655.
11. Schafer J, Hobel S, Bakowsky U, Aigner A. Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. Biomaterials. 2010;31:6892-900.
12. Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Nanotechnology-based approaches in anticancer research. Int J Nanomedicine. 2012;7:4391-408.
13. Luo X, Song X, Zhu A, Si Y, Ji L, Ma Z, et al. Development of poly(vinyl acetate-methylacrylic acid)/chitosan/Fe3O4 nanoparticles for the diagnosis of non-alcoholic steatohepatitis with magnetic resonance imaging. J Mater Sci Mater Med. 2012;23:3075-82.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001,25:402-8.
15. Schuldes H, Dolderer JH, Zimmer G, Knobloch J, Bickeboller R, Jonas D, et al. Reversal of multidrug resistance and increase in plasma membrane fluidity in CHO cells with R-verapamil and bile salts. Eur J Cancer. 2001;37:660-7.
16. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48-58.
17. Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials. 2010;31:358-65.
18. Chen BA, Sun Q, Wang XM, Gao F, Dai Y, Yin Y, et al. Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/AO2 leukemic cells. Int J Nanomed. 2008;3:277-86.
19. Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, Weller M, et al. Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res. 2008;14:2900-8.
20. Park SG, Jung S, Ryu HH, Jung TY, Moon KS, Kim IY et al. Role of 14-3-3-beta in the migration and invasion in human malignant glioma cell line U87MG. Neurol Res. 2012;3:893-900.
21. Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol. 2006;1:97-117.
22. Hao YX, He ZW, Zhu JH, Shen Q, Sun JZ, Du N, et al. Reversal of multidrug resistance in renal cell carcinoma by short hairpin RNA targeting MDR1 gene. Chin Med J (Engl). 2012;125:2741-5.
23. Garrigues A, Nugier J, Orlowski S, Ezan E. A High-throughput screening microplate test for the interaction of drugs with P-glycoprotein. Analytical Biochemistry. 2002;305:106-14.
24. Lin W, Zhang J, Zhang J, Liu X, Fei Z, Li X, et al. RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line. J Cell Mol Med. 2009;13:4608-22.
25. Valera ET, Lucio-Eterovic AK, Neder L, Scrideli CA, Machado HR, Carlotti-Junior CG, et al. Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system. J Neurooncol. 2007;85:1-10.
26. Gondi CS, Talluri L, Dinh DH, Gujrati M, Rao JS. RNAi-mediated downregulation of MMP-2 activates the extrinsic apoptotic pathway in human glioma xenograftcells. Int J Oncol. 2009;35:851-9.
27. de Verdière AC, Dubernet C, Némati F, Soma E, Appel M, Ferté J, et al. Reversion of multidrug resistance with polyalkylcyanoacryate nanoparticles: towards a mechanism of action. Br J Cancer. 1997;76:198-205.
28. Yaprak Donmez, Ufuk Gunduz. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicinresistant MCF-7 breast cancer cells. Biomed Pharmacother. 2011;65:85-9.